$1.31
-0.04-2.96%
Last update: Nov 11, 7:40 PM
Alzamend Neuro Inc
ALZNNASDAQ
Alzamend Neuro fell 44.0% from $2.34 to $1.31, behind the S&P 500's +11.2%. Its worst day was Mar 27 (−30.0%), and its low came Apr 10 at $0.86.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Alzamend Neuro closed at its highest level of the year, 4.3% above where the year started.
+4.3% · S&P 500 −0.8%
EPS of $-0.30 beat the $-1.51 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
−0.5% · S&P 500 +0.7%
EPS of $-0.58 beat the $-1.45 estimate on $0.00 revenue.
−4.1% · S&P 500 −1.5%
Alzamend Neuro shares fell 30.0%, while the S&P 500 fell 1.7%.
−30.0%, the year's worst day · S&P 500 −1.7%
Alzamend Neuro closed at its lowest level of the year, 63.4% below where the year started.
−5.0% · S&P 500 −0.1%
Alzamend Neuro shares rose 18.8%, while the S&P 500 rose 1.0%.
+18.8%, the year's best day · S&P 500 +1.0%
EPS of $-0.74 missed the $-0.67 estimate on $0.00 revenue.
−6.7% · S&P 500 −1.2%
EPS of $-0.68 missed the $-0.56 estimate on $0.00 revenue.
+1.2% · S&P 500 +0.9%
Alzamend Neuro shares fell 23.1%, while the S&P 500 rose 0.2%.
−23.1% · S&P 500 +0.2%
Alzamend Neuro shares rose 17.7%, while the S&P 500 rose 0.3%.
+17.7% · S&P 500 +0.3%
Where it ended: a close of $1.31 on Nov 11, 2026. Up next: Q2 2027 earnings on Dec 8, 2026 (EPS est. $-0.23).
Nothing in the past 12 months.
All ALZN dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ALZN and SPY from Benzinga historical bars. Not investment advice.
